BioSpace News Archive

Rapidly growing biotech will relocate to new lab and office space in early 2020

On Monday, July 22, 2019, Viper Equity Partners of Palm Beach announced strong Q2 results and its expanding reach into larger multi-location dental practice deals suitable for rapid value creation for its dental support organizations partners.

WellCare Health Plans, Inc. announced today Easy Choice Health Plan, Inc., a provider of Medicare Advantage plans in California, has officially rebranded and changed its name to WellCare of California, Inc.

NorthStar Medical Radioisotopes, LLC, a global innovator in the production and distribution of radioisotopes used for medical imaging, today announced that it has been awarded $15 million in a cooperative agreement with the U.S. Department of Energy’s National Nuclear Security Administration (DOE/NNSA) as part of an industry outreach initiative to establish reliable domestic molybdenum-99 (Mo-99) production without the use of highly enriched uranium.

Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that it will host a live webcast of its third quarter fiscal 2019 conference call on Wednesday, July 31, at 4 p.m. CT (5 p.m. ET).

MaxCyte, the global clinical-stage cell-based therapies and life sciences company, announced today that it has appointed Dr. Dhana Chinnasamy, a 20+-year expert in the research and translation of gene and immunotherapies, as its Vice President, Non-Clinical and Translational Studies.

DoctorLogic, the creators of the all-in-one Website Marketing Platform exclusively for healthcare providers, is proud to announce the launch of its newly redesigned website at https://www.doctorlogic.com.

Tridiuum, the leading provider of digital health solutions for accelerating behavioral and medical care integration, today announced its CFO, Ed Camarota, has been named CFO of the Year by the Philadelphia Business Journal.

Xylyx Bio, a pioneer in physiomimetic biomaterials, today announced that it has joined the Advanced Regenerative Manufacturing Institute (ARMI), a public-private Manufacturing USA initiative that supports the manufacturing of engineered tissues and tissue-related technologies.

Cellular Biomedicine Group Inc. (NASDAQ: CBMG) (“CBMG” or the “Company”), a biopharmaceutical firm engaged in the drug development of immunotherapies for cancer and stem cell therapies for degenerative diseases, today announced that it will release its financial results for the second quarter ended June 30, 2019 after the market closes on Tuesday, August 6, 2019.